BALAXI PHARMACEUTICALS
Back to Cashflow Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹34 Cr | ₹30 Cr | ₹26 Cr | ₹-0.16 Cr | ₹3.65 Cr |
What is the latest Cash Flow from Financing Activities ratio of BALAXI PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹-0.16 Cr |
| Mar2021 | ₹3.65 Cr |
How is Cash Flow from Financing Activities of BALAXI PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 11.97 | |
| Mar2024 | ₹30 Cr | 18.58 | |
| Mar2023 | ₹26 Cr | Positive | |
| Mar2022 | ₹-0.16 Cr | Negative | |
| Mar2021 | ₹3.65 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹126.2 Cr | -5.7% | -16.7% | -64.7% | Stock Analytics | |
| ADANI ENTERPRISES | ₹287,822.0 Cr | 15.2% | -1% | 0.4% | Stock Analytics | |
| REDINGTON | ₹20,994.6 Cr | 0.3% | -6.4% | 36.7% | Stock Analytics | |
| MMTC | ₹9,603.0 Cr | 0.3% | -5.4% | -6.3% | Stock Analytics | |
| HONASA CONSUMER | ₹9,279.6 Cr | 1.4% | -6.3% | 25.8% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹9,147.1 Cr | 10.7% | -6.2% | 23.3% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -5.7% |
-16.7% |
-64.7% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses